Investing.com - Truist Securities has lowered its price target on ICON plc (NASDAQ: ICLR) to $187.00 from $190.00 while maintaining a Buy rating on the stock. Currently trading at $152.45, ...

Investing.com - Truist Securities has lowered its price target on ICON plc (NASDAQ: ICLR) to $187.00 from $190.00 while maintaining a Buy rating on the stock.

Wasatch Global Investors, an asset management company, released its “Wasatch U.S. Select Strategy” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities ...

DUBLIN -- (BUSINESS WIRE)-- ICON plc (ICLR), (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON ...

DUBLIN 18, Ireland (AP) — Icon PLC (ICLR) on Wednesday reported first-quarter earnings of $154.2 million. The Dublin 18, Ireland-based company said it had profit of $1.90 per share. Earnings… ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Icon PLC (ICLR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is ...

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ICON PLC (ICLR), CLICK HERE BEFORE APRIL 11, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Icon Plc and Medpace are both CROs, but Icon focuses on large pharma with an aggressive M&A strategy, unlike Medpace's small biotech focus. Initially impressed by Icon's financials, we purchased ...

How to redeem Delta SkyMiles for the best value Use Delta SkyMiles for awards flights is generally the best way to get the most value.

ICON plc, a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Leerink Partners Global ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will ...